Clinical Trials Logo

Breast Neoplasms clinical trials

View clinical trials related to Breast Neoplasms.

Filter by:

NCT ID: NCT02103387 Completed - Breast Cancer Clinical Trials

Five Sessions Intervention to Facilitate Adaptation to Breast Cancer

Start date: January 2, 2007
Phase: N/A
Study type: Interventional

To test the effects of 2 different 5-wk stress management interventions (cognitive behavioral training or relaxation training) vs. a time-matched 5-wk health education condition on psychosocial adaptation and physiological adaptation in women being treated for breast cancer. Participants assigned to either of the stress management conditions will show improved psychosocial adaptation and physiological adaptation compared to those assigned to the health education condition.

NCT ID: NCT02102568 Completed - BREAST CANCER Clinical Trials

Impact of Chemo-induced Menopause on Quality of Life in Women <45 Years Old, Diagnosed With Non-metastatic Breast Cancer

MENOCOR
Start date: April 2014
Phase:
Study type: Observational

Prospective multicenter study, Not on Health Products that evaluates up to 2 and a half years the impact of chemo-induced menopause (CIM) on the functional score of the QLQ-C30 quality of life questionnaire in young women of childbearing age, diagnosed with non-metastatic breast cancer.

NCT ID: NCT02102490 Completed - Clinical trials for Metastatic Breast Cancer

A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread

MONARCH 1
Start date: June 10, 2014
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to evaluate whether the study drug known as abemaciclib is effective in treating participants with breast cancer who have already tried other drug treatments.

NCT ID: NCT02101970 Completed - Breast Cancer Clinical Trials

Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women

Start date: March 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if high dose supplementation with the omega-3 fatty acids EPA and DHA, when added to a weight loss program, is well tolerated in the study population and if there is an increase in the favorable change in blood and tissue breast cancer risk factors when compared to weight loss alone.

NCT ID: NCT02101385 Completed - Breast Cancer Clinical Trials

Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

Start date: April 3, 2014
Phase: Phase 2
Study type: Interventional

This study will test the theory that therapy designed for each individual's tumor will improve outcomes over standard of care in a population that needs a better standard.

NCT ID: NCT02101320 Completed - Breast Cancer Clinical Trials

Hand-held Gamma Camera in the SNOLL Procedure

TRECAM
Start date: May 20, 2015
Phase: N/A
Study type: Interventional

In France, breast cancer affects approximately 53,000 new cases per year. The investigators have to take care more and more women with subclinical lesions (nonpalpable), and it represents around 25% to 35% of the diagnosed breast cancers. The main problem of the surgical management of these lesions is the quality of preoperative identification which determines the quality of surgery and oncological and cosmetic outcomes. For this type of lesion, SNOLL (Sentinel Node and Occult Lesion Localization) procedure could be proposed. This is a radioactive labeling of the tumor site and sentinel lymph node (SLN). The investigators want to evaluate the potential benefits of using a hand held camera called TreCam in this SNOLL procedure. This camera permits to obtain nuclear imaging at the bedside and in the operating theater.

NCT ID: NCT02093039 Completed - Healthy Clinical Trials

Informed Decision Users of the Health System and Participation in Organized Screening for Breast Cancer

DECIDEO
Start date: May 2009
Phase: N/A
Study type: Interventional

The aim of this study is to assess the impact of a decision aid leaflet on the participation of women invited to participate in the French national breast cancer screening program.

NCT ID: NCT02092636 Completed - Breast Cancer Clinical Trials

Ultrasound and Near Infrared Imaging for Breast Cancer Diagnosis and Neoadjuvant Chemotherapy Monitoring

Start date: March 2014
Phase: N/A
Study type: Interventional

An imaging method has been developed that uses near infrared light as an adjunct to ultrasound for better diagnosis and for monitoring tumor response. This study will use a new, non-invasive way to evaluate breast lumps using a low power light source & ultrasound to see if breast lumps are benign or cancerous. This study will also evaluate if this new technique might be useful in assessing response to chemotherapy.

NCT ID: NCT02091960 Completed - Clinical trials for Advanced Breast Cancer

A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer

Start date: September 5, 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of enzalutamide with trastuzumab in patients with HER2+ AR+ metastatic or locally advanced breast cancer.

NCT ID: NCT02091765 Completed - Sexual Dysfunction Clinical Trials

RCT of an Internet-based CBT Program for Sexuality and Intimacy Problems in Women Treated for Breast Cancer

KIS
Start date: December 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and cost-effectiveness of an internet-based cognitive behavioural therapy program in alleviating problems with intimacy and sexuality in women treated for breast cancer.